phwin9

phwin9

NoneMaharashtra's New Leadership: A Coalition Power Play

Global Regulatory Compliance Software Market Size, Share and Forecast By Key Players-Badger, MetricStream, MasterControl, Enablon, SAP

Tenants at Two Rent-Controlled Buildings Suffer Through an Unheated ChristmasIsrael's military said yesterday it had killed two Hamas commanders, pressing its north Gaza offensive a day after the International Criminal Court (ICC) issued arrest warrants over the offensive. The Israeli Defense Forces (IDF) said an air strike on the territory's north killed five Hamas members including two company commanders "who participated in the October 7 massacre" last year. Medics said dozens were killed or missing after an overnight Israeli raid on Beit Lahia and nearby Jabalia, which are among the targets of a sweeping Israeli assault on north Gaza. A separate air attack targeted the Kamal Adwan Hospital – one of the few partially functioning medical facilities in the besieged territory's north. Residents claimed that Israeli soldiers yesterday set fire to residential buildings in Beit Lahiya to prevent families from returning to the area. Israeli gunboats have also fired at a fishing boat off the coast of Gaza City, killing one person and wounding another, report Al Jazeera online. Biden, in a statement later on Thursday responding to the ICC's arrest warrants for Israeli leaders, called them "outrageous", vowing to "always stand with Israel against threats to its security". China, which like Israel and the United States is not a member of the ICC, urged the court to "uphold an objective and just position". The Palestinian Authority and Hamas both welcomed the warrants, reports AFP. However, Irish Prime Minister Simon Harris said yesterday that Netanyahu would be detained if he arrives in Ireland. The head of Iran's Revolutionary Guards yesterday described the arrest warrant as the "end and political death" of Israel, in a speech. More than 44,056 people have been killed in Gaza in more than 13 months of offensive.

DORAL, Fla.--(BUSINESS WIRE)--Dec 23, 2024-- NeueHealth, Inc. (“NeueHealth” or the “Company”) (NYSE: NEUE), the value-driven healthcare company, today announced that it has entered into a definitive merger agreement pursuant to which the Company will be acquired by an affiliate of New Enterprise Associates (“NEA”) at an enterprise value of approximately $1.3 billion. Upon completion of the transaction, NeueHealth will become a privately held company with the flexibility and resources to continue advancing its value-driven, consumer-centric care model. Under the terms of the merger agreement, holders of NeueHealth common stock (other than shares that will be rolled over and certain excluded shares) will receive $7.33 per share in cash, which represents a premium of approximately 70% over the closing price of NeueHealth common stock on December 23, 2024. Certain stockholders of NeueHeath, including NEA and 12 existing NeueHealth investors (which collectively hold all of the outstanding shares of NeueHealth preferred stock), have entered into rollover agreements pursuant to which such stockholders will continue their investments by exchanging their shares of NeueHealth common stock and/or preferred stock for newly issued equity interests in the privately held company, and the Company’s existing secured loan facility with Hercules Capital, Inc. will remain in place. NeueHealth’s executive leadership team will continue in their roles upon completion of the transaction and intends to roll over 100% of their equity interests for newly issued equity interests in the privately held company. “We are pleased to announce this transaction as we believe it places NeueHealth in a strong position for continued growth while maximizing value for all of NeueHealth’s public stockholders,” said Mike Mikan, President and CEO of NeueHealth. “NEA has been a longstanding strategic partner, and we look forward to continuing to work together to build on NeueHealth’s success as a leader in value-based care.” “We believe NeueHealth has built a differentiated model of care that is uniquely positioned to drive value for consumers, providers, and payors and we have confidence in the NeueHealth team and their ability to continue to lead the Company,” said Mohamad Makhzoumi, Co-CEO of NEA. “We have had a strong partnership with NeueHealth since 2016 and share the Company’s commitment to making high-quality healthcare accessible and affordable for all Americans.” Transaction Details A special committee (the “Special Committee”) of the board of directors of NeueHealth (the “Board”), composed entirely of independent and disinterested directors and advised by its own independent legal and financial advisors, unanimously recommended that the Board approve the transaction and determined it was in the best interests of the Company and its stockholders that are not affiliated with NEA. Acting upon the recommendation of the Special Committee, the Board subsequently unanimously approved the transaction and determined to recommend that NeueHealth stockholders vote to approve and adopt the merger agreement. Certain NeueHealth stockholders have agreed to vote all of their shares of NeueHealth common stock and/or preferred stock to approve and adopt the merger agreement, subject to certain conditions. The merger is subject to approval by NeueHealth’s stockholders and other customary closing conditions, including receipt of certain regulatory approvals. NEA intends to finance the transaction with fully committed equity financing, and the transaction is not subject to any financing condition. Upon completion of the transaction, NeueHealth’s common stock will no longer be publicly traded or listed on any public market. The merger agreement includes a 30-day “go-shop” period that will expire at 12:01 AM New York City time on January 23, 2025, which permits the Special Committee and its financial advisors to solicit and consider alternative acquisition proposals. There can be no assurance that this process will result in a superior proposal, and NeueHealth does not intend to disclose developments with respect to the “go-shop” process unless and until it determines such disclosure is appropriate or is otherwise required. Lincoln International, LLC is acting as financial advisor, and Richards, Layton & Finger, P.A. is acting as legal counsel, to the Special Committee. Simpson Thacher & Bartlett LLP is acting as legal counsel to NeueHealth. Latham and Watkins LLP is acting as legal counsel to NEA, with Sidley Austin LLP acting as insurance regulatory counsel to NEA. More information regarding the key terms will be included in a current report on Form 8-K to be filed by NeueHealth with the Securities and Exchange Commission (the “SEC”). Important Information and Where to Find It In connection with the transaction, the Company will file with the SEC a proxy statement on Schedule 14A (the “Proxy Statement”), the definitive version of which will be sent or provided to Company stockholders. The Company, affiliates of the Company and affiliates of NEA intend to jointly file a transaction statement on Schedule 13E-3 (the "Schedule 13E-3") with the SEC. The Company may also file other documents with the SEC regarding the transaction. This release is not a substitute for the Proxy Statement, the Schedule 13E-3 or any other document which the Company may file with the SEC. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE PROXY STATEMENT, THE SCHEDULE 13E-3 AND ANY OTHER RELEVANT DOCUMENTS THAT ARE FILED OR WILL BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY BEFORE MAKING ANY VOTING OR INVESTMENT DECISION WITH RESPECT TO THE COMPANY OR THE TRANSACTION BECAUSE THESE DOCUMENTS CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT THE TRANSACTION AND RELATED MATTERS. Investors and security holders may obtain free copies of the Proxy Statement, the Schedule 13E-3 and other documents that are filed or will be filed with the SEC by the Company, when such documents become available, through the website maintained by the SEC at www.sec.gov or through the Company's website at https://investors.neuehealth.com/home/default.aspx . The transaction will be implemented solely pursuant to the Agreement and Plan of Merger, dated as of December 23, 2024 (the “merger agreement”), among the Company, NH Holdings 2025, Inc. and NH Holdings Acquisition 2025, Inc., which contains the full terms and conditions of the transaction. Participants in the Solicitation The Company and certain of its directors, executive officers and employees may be deemed to be participants in the solicitation of proxies from stockholders of the Company in connection with the proposed transaction. Information regarding the Company’s directors and executive officers is available in the definitive proxy statement for the 2024 annual meeting of stockholders of the Company, which was filed by the Company with the SEC on April 1, 2024 (the “Annual Meeting Proxy Statement”), and will be available in the Proxy Statement. Please refer to the sections captioned “Executive Compensation,” “Director Compensation,” and “Security Ownership of Certain Beneficial Owners and Management” in the Annual Meeting Proxy Statement. Holdings of the Company’s securities by certain of the Company’s employees, and any changes in the holdings of the Company’s securities by the Company’s directors or executive officers from the amounts described in the Annual Meeting Proxy Statement, have been reflected in the following Statements of Change in Ownership on Form 4 filed with the SEC: Form 4, filed by George Lawrence Mikan III on May 6, 2024; Form 4, filed by Jay Matushak on May 6, 2024; Form 4, filed Tomas Orozco on May 6, 2024; Form 4, filed by Jeffery Michael Craig on May 6, 2024; Form 4, filed by Jeffrey J. Scherman on May 6, 2024; Form 4, filed by Jay Matushak on May 13, 2024; Form 4, filed by Jeffrey J. Scherman on May 13, 2024; Form 4, filed by Kedrick D. Adkins, Jr. on May 14, 2024; Form 4, filed by Andrew M. Slavitt on May 14, 2024; Form 4, filed by Linda Gooden on May 14, 2024; Form 4, filed by Mohamad Makhzoumi on May 14, 2024; Form 4, filed by Robert J. Sheehy on May 14, 2024; Form 4, filed by Matthew G. Manders on May 14, 2024; Form 4, filed by Stephen Kraus on May 14, 2024; Form 4, filed by Manuel Kadre on May 14, 2024; Form 4, filed by Jeffrey R. Immelt on May 14, 2024; Form 4, filed by Mohamad Makhzoumi on October 3, 2024; Form 4, filed by Jay Matushak on October 8, 2024; Form 4, filed by George Lawrence Mikan III on December 18, 2024. Other information regarding the participants in the proxy solicitation and a description of their direct and indirect interests, by security holdings or otherwise, will be contained in the Proxy Statement and other relevant materials to be filed with the SEC in connection with the proposed transaction when they become available. Free copies of the Proxy Statement and such other materials may be obtained as described in the preceding paragraph. About NeueHealth NeueHealth is a value-driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated care. By uniquely aligning the interests of health consumers, providers, and payors, NeueHealth helps to make healthcare accessible and affordable to all populations across the ACA Marketplace, Medicare, and Medicaid. NeueHealth delivers high-quality clinical care to over 500,000 health consumers through owned clinics and unique partnerships with over 3,000 affiliated providers. We also enable independent providers and medical groups to thrive in performance-based arrangements through a suite of technology and services scaled centrally and deployed locally. We believe our value-driven, consumer-centric care model can transform the healthcare experience and maximize value across the healthcare system. For more information, visit: www.neuehealth.com . About NEA New Enterprise Associates (NEA) is a global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors and geographies. Founded in 1977, NEA has more than $25 billion in assets under management as of June 30, 2024 and invests in technology and healthcare companies at all stages in a company’s lifecycle, from seed stage through IPO. The firm's long track record of investing includes more than 280 portfolio company IPOs and more than 465 mergers and acquisitions. For more information, please visit www.nea.com . Forward-Looking Statements This release contains certain “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Statements made in this release that are not statements of historical fact, including statements about our beliefs and expectations, are forward-looking statements and should be evaluated as such. Forward-looking statements include information concerning possible or assumed future results of operations, including descriptions of our business plan and strategies, and statements as to the expected timing, completion and effects of the transaction. These statements often include words such as “anticipate,” “expect,” “plan,” “believe,” “intend,” “project,” “forecast,” “estimates,” “projections,” “outlook,” “ensure,” and other similar expressions. These forward-looking statements include any statements regarding our plans, expectations and financial guidance. Such forward-looking statements are subject to various risks, uncertainties and assumptions. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. Factors that might materially affect such forward-looking statements include: the failure to complete the transaction on the anticipated terms and within the anticipated timeframe, including as a result of failure to obtain required stockholder or regulatory approvals or to satisfy other closing conditions; potential litigation relating to the transaction that could be instituted against NEA, the Company or their respective affiliates, directors, managers, officers or employees, and the effects of any outcomes related thereto; potential adverse reactions or changes to our business relationships or operating results resulting from the announcement, pendency or completion of the transaction; the risk that our stock price may decline significantly if the transaction is not consummated; certain restrictions during the pendency of the transaction that may impact our ability to pursue certain business opportunities or strategic transactions; costs associated with the transaction, which may be significant; the occurrence of events, changes or other circumstances that could give rise to the termination of the merger agreement, including in circumstances requiring us to pay a termination fee; our ability to continue as a going concern; our ability to comply with the terms of our credit facilities­ or any credit facility into which we enter in the future; our ability to receive the remaining proceeds from the sale of our Medicare Advantage business in California in a timely manner; our ability to obtain any short or long term debt or equity financing needed to operate our business; our ability to quickly and efficiently complete the wind down of our remaining Individual and Family Plan (“IFP”) and MA businesses, including by satisfying liabilities of those businesses when due and payable; potential disruptions to our business due to the transaction or due to corporate restructuring and any resulting headcount reduction; our ability to accurately estimate and effectively manage the costs relating to changes in our business offerings and models; a delay or inability to withdraw regulated capital from our subsidiaries; a lack of acceptance or slow adoption of our business model; our ability to retain existing consumers and expand consumer enrollment; our and our care partner’s abilities to obtain and accurately assess, code, and report risk adjustment factor scores; our ability to contract with care providers and arrange for the provision of quality care; our ability to obtain claims information timely and accurately; the impact of any pandemic or epidemic on our business and results of operations; the risks associated with our reliance on third-party providers to operate our business; the impact of modifications or changes to the U.S. health insurance markets; our ability to manage any growth of our business; our ability to operate, update or implement our technology platform and other information technology systems; our ability to retain key executives; our ability to successfully pursue acquisitions, integrate acquired businesses, and quickly and efficiently divest businesses as needed; the occurrence of severe weather events, catastrophic health events, natural or man-made disasters, and social and political conditions or civil unrest; our ability to prevent and contain data security incidents and the impact of data security incidents on our members, patients, employees and financial results; our ability to comply with requirements to maintain effective internal controls; our ability to adapt to mitigate risks associated with our ACO businesses, including any unanticipated market or regulatory developments; and the other factors set forth under the heading “Risk Factors” in the Company’s reports on Form 10-K, Form 10-Q, and Form 8-K (including all amendments to those reports) and our other filings with the SEC. Except as required by law, we undertake no obligation to update publicly any forward-looking statements for any reason after the date of this release to conform these statements to actual results or changes in our expectations. View source version on businesswire.com : https://www.businesswire.com/news/home/20241223595862/en/ CONTACT: Investor Contact: IR@neuehealth.comMedia Contact: media@neuehealth.com KEYWORD: FLORIDA UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: PRACTICE MANAGEMENT PROFESSIONAL SERVICES MANAGED CARE HEALTH GENERAL HEALTH HEALTH TECHNOLOGY HEALTH INSURANCE HOSPITALS INSURANCE TELEMEDICINE/VIRTUAL MEDICINE FINANCE SOURCE: NeueHealth Copyright Business Wire 2024. PUB: 12/23/2024 05:53 PM/DISC: 12/23/2024 05:53 PM http://www.businesswire.com/news/home/20241223595862/enThe AP Top 25 men’s college basketball poll is back every week throughout the season! Get the poll delivered straight to your inbox with AP Top 25 Poll Alerts. Sign up here . DAYTONA BEACH, Fla. (AP) — RJ Felton had 21 points in East Carolina’s 71-64 victory over Stetson on Friday. Felton also added eight rebounds for the Pirates (5-1). Joran Riley scored 14 points while going 4 of 11 and 5 of 6 from the free-throw line and added five rebounds. Cam Hayes shot 3 for 7 (2 for 4 from 3-point range) and 5 of 6 from the free-throw line to finish with 13 points. The Hatters (1-5) were led in scoring by Mehki, who finished with 15 points and two steals. Abramo Canka added 14 points for Stetson. Jordan Wood had 12 points. East Carolina led Stetson at the half, 39-33, with Hayes (10 points) its high scorer before the break. East Carolina took the lead for good with 6:56 left in the second half on a free throw from Felton to make it a 60-59 game. ___ The Associated Press created this story using technology provided by Data Skrive and data from Sportradar .

Advisors Asset Management Inc. lessened its position in shares of Canadian Solar Inc. ( NASDAQ:CSIQ – Free Report ) by 34.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 6,892 shares of the solar energy provider’s stock after selling 3,695 shares during the period. Advisors Asset Management Inc.’s holdings in Canadian Solar were worth $116,000 at the end of the most recent reporting period. Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Quarry LP acquired a new position in shares of Canadian Solar in the 2nd quarter valued at about $31,000. Private Advisor Group LLC purchased a new position in Canadian Solar in the third quarter valued at approximately $219,000. Northwestern Mutual Wealth Management Co. lifted its position in Canadian Solar by 43.1% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 15,733 shares of the solar energy provider’s stock valued at $232,000 after buying an additional 4,739 shares in the last quarter. Harel Insurance Investments & Financial Services Ltd. grew its stake in Canadian Solar by 27.6% during the second quarter. Harel Insurance Investments & Financial Services Ltd. now owns 17,435 shares of the solar energy provider’s stock worth $257,000 after buying an additional 3,768 shares during the period. Finally, American Century Companies Inc. increased its position in shares of Canadian Solar by 8.0% in the second quarter. American Century Companies Inc. now owns 18,716 shares of the solar energy provider’s stock worth $276,000 after acquiring an additional 1,383 shares in the last quarter. 52.36% of the stock is currently owned by institutional investors and hedge funds. Analyst Upgrades and Downgrades Several analysts recently issued reports on CSIQ shares. Oppenheimer lowered their price target on Canadian Solar from $43.00 to $27.00 and set an “outperform” rating for the company in a report on Friday, August 23rd. Citigroup lowered Canadian Solar from a “neutral” rating to a “sell” rating and lowered their target price for the company from $19.00 to $11.00 in a research note on Tuesday, October 22nd. Jefferies Financial Group began coverage on Canadian Solar in a research report on Friday, November 22nd. They set a “buy” rating and a $14.15 price target on the stock. The Goldman Sachs Group lowered their price objective on shares of Canadian Solar from $18.00 to $16.00 and set a “neutral” rating for the company in a research report on Monday, August 26th. Finally, Roth Mkm decreased their target price on shares of Canadian Solar from $25.00 to $20.00 and set a “buy” rating for the company in a research note on Monday, August 26th. Four equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and four have issued a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $19.94. Canadian Solar Trading Down 2.7 % CSIQ opened at $12.41 on Friday. Canadian Solar Inc. has a 12-month low of $10.91 and a 12-month high of $26.85. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.04 and a quick ratio of 0.82. The stock has a market capitalization of $821.05 million, a PE ratio of 25.29, a P/E/G ratio of 2.26 and a beta of 1.34. The firm’s fifty day moving average price is $13.63 and its 200 day moving average price is $14.88. Canadian Solar Company Profile ( Free Report ) Canadian Solar Inc, together with its subsidiaries, provides solar energy and battery energy storage products and solutions in in Asia, the Americas, Europe, and internationally. The company operates through two segments, CSI Solar and Recurrent Energy. The CSI Solar segment designs, develops, and manufactures solar ingots, wafers, cells, modules, and other solar power and battery storage products. Read More Five stocks we like better than Canadian Solar Business Services Stocks Investing The Latest 13F Filings Are In: See Where Big Money Is Flowing How to Invest in Blue Chip Stocks 3 Penny Stocks Ready to Break Out in 2025 Stock Trading Terms – Stock Terms Every Investor Needs to Know FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential Want to see what other hedge funds are holding CSIQ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Canadian Solar Inc. ( NASDAQ:CSIQ – Free Report ). Receive News & Ratings for Canadian Solar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canadian Solar and related companies with MarketBeat.com's FREE daily email newsletter .

WASHINGTON (AP) — Lawmakers, meet your latest lobbyists: online influencers from TikTok. The platform is once again bringing influencers to Washington, this time to lobby members of Congress to reject a fast-moving bill that would force TikTok's Beijing-based parent company to sell or be banned in the United States. On Tuesday, some influencers began a two-day advocacy event in support of TikTok, which arranged their trip ahead of a House floor vote on the legislation on Wednesday. But unlike a similar lobbying event the company put together last March when talks of a TikTok ban reached a fever pitch, this year’s effort appeared more rushed as the company scrambles to counter the legislation, which advanced rapidly on Capitol Hill. Summer Lucille, a TikTok content creator with 1.4 million followers who is visiting Washington this week, said if TikTok is banned, she “don’t know what it will do” to her business, a plus-sized boutique in Charlotte, North Carolina. “It will be devastating,” Lucille said in an interview arranged by the platform. In an unusual showing of bipartisanship, a House panel unanimously approved the measure last week. President Joe Biden has said he will sign the legislation if lawmakers pass it. But it’s unclear what will happen in the Senate, where several bills aimed at banning TikTok have stalled. The legislation faces other roadblocks. Former president and current presidential candidate Donald Trump, who holds sway over both House and Senate Republicans, has voiced opposition to the bill, saying it would empower Meta-owned Facebook, which he continues to lambast over his 2020 election loss. The bill also faces pushback from some progressive lawmakers in the House as well as civil liberties groups who argue it infringes on the First Amendment. TikTok could be banned if ByteDance, the parent company, doesn’t sell its stakes in the platform and other applications it owns within six months of the bill’s enactment. The fight over the platform takes place as U.S.-China relations have shifted to that of strategic rivalry, especially in areas such as advanced technologies and data security, seen as essential to each country’s economic prowess and national security. The shift, which started during the Trump years and has continued under Biden, has placed restrictions on export of advanced technologies and outflow of U.S. monies to China, as well as access to the U.S. market by certain Chinese businesses. The Biden administration also has cited human rights concerns in blacklisting a number of Chinese companies accused of assisting the state surveillance campaign against ethnic minorities. TikTok isn’t short on lobbyists. Its Beijing-based parent company ByteDance has a strong lobbying apparatus in Washington that includes dozens of lobbyists from well-known consulting and legal firms as well as influential insiders, such as former members of Congress and ex-aides to powerful lawmakers, according to the Foundation for Defense of Democracies. TikTok CEO Shou Zi Chew will also be in Washington this week and plans to meet with lawmakers, according to a company spokesperson who said Chew’s visit was previously scheduled. But influencers, who have big followings on social media and can share personal stories of how the platform boosted their businesses — or simply gave them a voice — are still perhaps one of the most powerful tools the company has in its arsenal. A TikTok spokesperson said dozens of influencers will attend the two-day event, including some who came last year. The spokesperson did not immediately respond to questions about how many new people would be attending this year’s lobbying blitz. The company is briefing them ahead of meetings with their representatives and media interviews. Lucille, who runs the boutique in North Carolina, says has seen a substantial surge in revenue because of her TikTok page. The 34-year-old began making TikTok content focusing on plus-sized fashion in March 2022, more than a decade after she started her business. She quickly amassed thousands of followers after posting a nine-second video about her boutique. Because of her popularity on the platform, her business has more online exposure and customers, some of whom have visited from as far as Europe. She says she also routinely hears from followers who are finding support through her content about fashion and confidence. JT Laybourne, an influencer who also came to Washington, said he joined TikTok in early 2019 after getting some negative comments on videos he posted on Instagram while singing in the car with his children. Laybourne, who lives in Salt Lake City, Utah, said he was attracted to the short-form video platform because it was easy to create videos that contained music. Like Lucille, he quickly gained traction on the app. He says he also received more support from TikTok users, who reacted positively to content he produced on love and positivity. Laybourne says the community he built on the platform rallied around his family when he had to undergo heart surgery in 2020. Following the surgery, he said he used the platform to help raise $1 million for the American Heart Association in less than two years. His family now run an apparel company that gets most of its traffic from TikTok. “I will fight tooth-and-nail for this app,” he said. But whether the opposition the company is mounting through lobbyists or influencers will be enough to derail the bill is yet to be seen. On Tuesday, House lawmakers received a briefing on national security concerns regarding TikTok from the FBI, Justice Department and intelligence officials. AP Journalist Didi Tang contributed to this report. This story was originally published on March 12, 2024. It was updated on December 23, 2024 to clarify a quote by TikTok content creator Summer Lucille.Arsenal manager Mikel Arteta has cooled injury fears around Bukayo Saka and Riccardo Calafiori , but admitted he was forced to take Gabriel off against West Ham. Gabriel, who opened the scoring in Arsenal’s eventful 5-2 win over at the Hammers on Saturday evening, was substituted at half-time at the London Stadium as Jakub Kiwior came on in his place. It was the second game in a row in which the defender was forced off, having also been substituted late on in the 5-1 Champions League win at Sporting CP on Tuesday night. Arteta confirmed it was the same issue that meant Gabriel - who also won Arsenal’s second penalty before half-time on Saturday after being fouled by West Ham goalkeeper Lukasz Fabianski - had to be withdrawn again, but Arsenal will hope it is nothing serious as they prepare to host Manchester United next in the Premier League on Wednesday night. “It was related to the previous injury he had in Lisbon,” said Arteta. “He did great to be a part of that. With that result and the state he is feeling, we decided to take him off.” Calafiori and Saka also both came off during Arsenal’s thumping win at West Ham, likewise Martin Odegaard who stayed down briefly after an earlier challenge from Max Kilman. Saka was substituted with 16 minutes to go having earlier needed treatment after being hurt during a collision with Emerson following a shot, but Arteta said afterwards: “He’s fine.” There was more concern over Calafiori, who was forced to come off before the hour mark in east London. The Italian has battled with injuries this season, most recently a knee problem picked up in October, and Arteta hinted this latest move was a precaution. “Well, he’s been dealing with little niggles in the last few weeks. Obviously, he’s had a very serious knee injury and he’s doing really well, but we have to manage his minutes,” said Arteta. “Today we have to do the same.” Arsenal were without midfielders Thomas Partey (muscle) and Mikel Merino (knee) against West Ham due to new injuries, while Arteta revealed that youngster Myles Lewis-Skelly also sustained an issue on Friday, with fellow defenders Ben White and Takehiro Tomiyasu already out. “We had an issue with Gabby and then an issue with Ricci as well,” Arteta said. “Obviously yesterday we lost Thomas and Mikel and Myles, which was very bad news but what I am really happy about is Jakub has to come in, he does really well. Alex [Zinchenko] the same, Jorginho I think he was exceptional. “That’s the level. Every three days we’re going to need everyone at their best and it’s a good sign the team can do that.” The Gunners were in fine form against West Ham, scoring five goals for the second match in a row this week. The win moves them up to second in the Premier League table, six points off leaders Liverpool - who host Manchester City on Sunday. “We are in a great moment right now, but in football be on your toes and prepare the best possible way for tomorrow,” said Arteta. “Because it is so competitive this league, the opposition that we’re playing every three days, that’s the only thing that you can do. We can analyse a lot of things to improve today, again tomorrow. “We’ve got some momentum. I think we have some flow back, a real determination. Winning consecutive matches against three opponents is great and we’re going to enjoy tonight and watch a beautiful game of football tomorrow.”

The holidays are known as the shopping season. But as soon as they are over, Americans switch into the return season. Shoppers returned $743 billion worth of merchandise in 2023, according to the State of Retail Returns 2024 report by Optoro. The average return rate across channels was 14.5% last year (17.6% for goods purchased online and 10% for items purchased at brick-and-mortar stores). Do retailers have to accept returns? There is no federal law requiring stores to accept returns. But some states have return and refund laws, and New York is one of them. New York state law does not require retailers to accept returns. However, if they do not, the law requires them to post a conspicuous notice visible to consumers before the point of sale advising that no returns will be accepted. If a retailer does not post a return policy, New York law requires them to accept returns of unused, undamaged merchandise within 30 days of the purchase. The returned item must include a proof of purchase and the refund must be in the form of cash or credit based on the customer’s preference. For retailers that allow returns, New York requires that the form of the refund – cash, credit or exchange – be clearly disclosed in advance of the purchase. Can stores charge a “restocking” fee? New York law does not prohibit retailers from charging a fee for returns. However, they must disclose any such fees – often labeled as a “restocking fee” – before the sale. “If no fee is listed, customers should inquire whether the store imposes a re-stocking fee for returned merchandise and determine prior to purchase if the item can be returned for a refund or only store credit,” the state Division of Consumer Protection advises. The department also recommends consumers hold on to receipts and packaging in case an item needs to be returned. And if purchasing gifts, ask if a gift receipt is available, it suggests. How to file a complaint or get help Consumers who are having trouble obtaining a refund can file a complaint online via the Division of Consumer Protection website. Consumers can also download a printable complaint form from the website that can be mailed to the division. The division also provides voluntary mediation between a consumer and a business when a consumer has been unable to reach a resolution on their own. The Consumer Assistance Helpline 1-800-697-1220 is available Monday through Friday from 8:30 a.m. to 4:30 p.m., excluding holidays.'Ignore us at your peril': Students join climate protest with a sober warning